Recently Added Records

Researchers at IHME systematically reviewed, identified, and extracted data from scientific literature studies that estimated the reduction in risk of COVID-19 among individuals with a past SARS-CoV-2 infection in comparison to those without a previous infection. The outcomes assessed were reinfection, symptomatic reinfection, and severe reinfection (hospitalization or death). Extracted SARS-CoV-2 lineages were ancestral, mixed (two different specified variants – e.g., ancestral and Alpha), Alpha (B.1.1.7), Beta (B.1.351), Delta (B.1.617.2), and Omicron (BA.1) and its sub-lineages (BA.2, BA.4/BA.5). A total of 65 studies from 19 different countries were identified. The researchers also produced a meta-analysis of the effectiveness of past infection by outcome (infection, symptomatic disease, and severe disease), variant, and time since infection.

Research by the Global Burden of Disease Health Financing Collaborator Network produced projected health spending estimates for 2020-2050 for 204 countries and territories. The estimates cover total health spending, health spending disaggregated by source into three domestic financing source categories (government, out-of-pocket, and prepaid private), and development assistance for health (DAH). Retrospective health spending estimates for 1995-2019 and key covariates (including GDP per capita, total government spending, total fertility rate, and fraction of the population older than 65 years) were used to forecast GDP and health spending through 2050. Estimates are reported in constant 2021 US dollars, constant 20201purchasing-power parity-adjusted (PPP) dollars, and as a percent of gross domestic product.

This version of the Development Assistance for Health (DAH) Database includes estimates for 1990-2021, which are based on project databases, financial statements, annual reports, IRS 990s, and correspondence with agencies. The DAH Database enables comprehensive analysis of trends in international disbursements of grants and loans for health projects in low- and middle-income countries from key agencies. The data are disaggregated by source of funds, channel of funding, country and geographic region, health focus areas, and program areas.
To better understand the data and how to use it, please refer to the IHME DAH Database 2021 User Guide.

Development Assistance for Health (DAH) on COVID-19 produced estimates for 2020-2021, which are based on project databases, financial statements, annual reports, IRS 990s, and correspondence with agencies. The DAH Database enables comprehensive analysis of trends in international disbursements of grants and loans for COVID-19-related health projects in low- and middle-income countries from key agencies. The data are disaggregated by source of funds, channel of funding, country and geographic region, and program areas.

This dataset provides estimates of vaccination coverage for meningococcal serogroup A conjugate vaccine (MenAfriVac®) for 24 countries in the meningitis belt of sub-Saharan Africa between 2010 and 2021. Indicators include mean and 95% uncertainty intervals for the estimated coverage for children aged 1 to 5 and children and young adults aged 1 to 29. These estimates include coverage from both mass vaccination campaigns and routine immunization delivery. The estimation process primarily utilized survey report data and country-reported administrative vaccine coverage data.

This dataset includes total cardiovascular disease burden estimates globally for multiple cardiovascular diseases for 7 Global Burden of Disease Study (GBD) super regions, 21 GBD regions, 204 countries and territories, and select subnational locations. The following are reported: mortality by age and sex for the years 1990 and 2021; age-standardized mortality in 2021 by Socio-Demographic Index (SDI), a composite indicator of fertility, income, and education; all ages and age-standardized prevalence for 2021; and age-standardized disability-adjusted life years (DALYs) for 2021. The dataset also includes burden attributable to selected risk factors for each GBD region in 2021, as measured by DALYs. These data are custom calculated for publication in the Journal of the American College of Cardiology and will not be available in the GBD 2021 Results Tool.

The Saint Vincent and the Grenadines Population and Vital Statistics Report 2019 presents figures on population, live births, stillbirths, registered deaths, underlying cause of death, marriages, and divorces.

Data presented have been collected by the country's Registry Department and have been calculated by its Statistical Office. Figures on population totals come from the decennial Population and Housing Census.

Part of the National Program of Health Statistics' Series 5 on Vital Statistics, issue no. 64 contains tabulated data on registered births, deaths, fetal deaths, and marriages.

Estimates were produced for mortality rates, life expectancy, and population at the state level in the United States, and by racial/ethnic group, for each year between 1990-2019. These estimates were produced using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

• CSV files of state-, and national-level estimates of mortality rates and life expectancy for each age group, sex, year, and racial-ethnic group (non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic, Other). Blank cells are for masked estimates
• Code used to generate the estimates

These development assistance for human resources for health (DAHRH) estimates are generated using data from IHME’s Development Assistance for health Database DAH, COVID development assistance database and the Organization for Economic Cooperation and Development’s Creditor Reporting System (CRS) online database. The IHME databases enables comprehensive analysis of donor funding aimed towards activities that support the health workforce in low- and middle-income countries from key agencies. The DAHRH estimates are disaggregated by source of funds, channel (disbursing agency) of funding, geographic region (Global Burden of Disease Study (GBD) super region), and the type of human resources for health activities supported (program areas).

Researchers at IHME produced estimates for age-specific Healthcare Access and Quality (HAQ) indices for ten year intervals from 1990-2016. The US national age-specific HAQ scores were compared with high-income peers (Canada, Western Europe, High-Income Asia Pacific countries, and Australasia) in 1990, 2000, 2010, and 2016. Scores among US states were also analyzed for 2010 and 2016. The public use microdata sample of the American Community Survey was used to estimate insurance coverage and the median income per person by age and state.

This dataset contains estimates on the cost-effectiveness of HPV vaccination in 195 countries. The probability that HPV vaccination was cost-saving in each country was predicted using a logistic regression model, and is reported by incremental cost-effectiveness ratio (ICER). Data used to produce the estimates came from 638 ICERs reported in 76 studies from the Tufts University’s Cost-Effectiveness Analysis (CEA) Registry and the Global Health CEA Registry.

The COVID-19 Health Services Disruption Survey 2020 is a series of surveys developed to assess the level of disruption to a range of health services resulting from the COVID-19 pandemic and subsequent government mandates and changes in behavior to mitigate the spread of the disease.

The IPSOS General Population COVID-19 Health Services Disruption Survey 2020 was conducted by IPSOS via telephone and online surveys in 14 countries. Respondents were individual members of the general population. Data were collected from 15,258 respondents. The survey focused on the level of disruption to the provision of general health services, including visits to medical providers and access to medication.

This survey was developed specifically to assess the change in levels of service delivery prior to, and immediately following, the onset of the COVID-19 global pandemic. Data generated from this survey are not intended to be used as an overall estimate of the level of health service delivery.

This dataset contains estimates for deaths and years of life lost (YLLs) attributable to non-optimal temperature exposure (including high temperature, low temperature, and the aggregate non-optimal temperature risk) for 204 countries, Global Burden of Disease Study (GBD) regions and super regions, and globally for the years 1990, 2010, and 2010. These estimates inform a paper published in The Lancet in August 2021 titled “Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study.”

The study Health Behavior among Estonian Adult Population has been conducted every two years since 1990. A sample of 5,000 Estonian residents ages 16-64 years were selected from the Population Register and were sent a survey questionnaire through the mail. Additionally, county samples were included (n=7400) to analyze health indicators for the 15 counties and two largest city divisions in Estonia.

The questionnaire collected information on the participants' health status, use of health services and medications, physical activity, smoking and alcohol use, dietary habits, and demographic information. 

This dataset contains retrospective estimates for healthcare spending attributable to dementia for 195 countries from 2000 to 2019 and prospective spending estimates from 2020 to 2050 under multiple scenarios. Intermediate and final estimates are provided. Intermediate estimates include community based care rate (CBC), nursing home based care rate (NHBC), community based care unit cost, and nursing home based care unit cost. Final estimates are attributable dementia spending. All spending is reported in 2019 United States dollars. Future estimates report the same model outputs as those reported in the retrospective model but include both reference and alternative scenarios based on accelerated care setting rates and units costs.

The 2019 survey was conducted in November, and collected data on health status, physical activity, nutrition, and food intake of the Japanese population. For this year, data on health disparities was a focus of the survey.

Before 2003, the National Health and Nutrition Survey was known as the National Nutrition Survey.

Estimates of vaccination coverage for 11 childhood vaccines (first-dose bacillus Calmette-Guérin [BCG], first- and third-dose diphtheria-tetanus-pertussis [DTP1, DTP3], third-dose hepatitis B [HepB3], third-dose Haemophilus influenzae type b [Hib3], first- and second-dose measles [MCV1, MCV2], third-dose pneumococcal conjugate vaccine [PCV3], third-dose polio [Pol3], first-dose rubella-containing vaccine [RCV1], and complete rotavirus [RotaC, two or three doses]) were produced for 204 countries and territories between 1980 and 2019 as part of the Global Burden of Disease Study 2020, Release 1 (GBD 2020 R1). The estimation process primarily utilized household survey microdata, household survey report data in the absence of microdata, and estimates of country-reported coverage data.

This dataset includes the following:

• CSV files for national-level estimates of vaccine coverage, by vaccine
• Code files used to generate the estimates

The Global Burden of Disease Study 2019 (GBD 2019), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Estimates of smoking tobacco use and the burden attributable to this risk factor were produced by sex, age group, and year for 204 countries and territories for 1990-2019. Files available in this record include estimates of the prevalence of smoking tobacco use, number of people that currently use smoked tobacco products, and supply-side tobacco availability and consumption. Estimates of disease burden attributable to smoking tobacco use are available through the GBD Results Tool.

For additional GBD results and resources, visit the GBD 2019 Data Resources page.

Part of the National Program of Health Statistics' Series 5 on Vital Statistics, issue no. 63 contains tabulated data on registered births, deaths, fetal deaths, and marriages.

The Infectious Disease Weekly Report (IDWR) tabulations Sentinel-Reporting Diseases provides cumulative cases of sentinel reporting diseases by prefecture reported in Japan during 2017. Case totals are provided for the country and by prefecture for 2017. Infectious disease case notification data for Japan, provided in the Infectious Disease Weekly Report (IDWR), are collected by the Infectious Disease Surveillance Center for the National Epidemiological Surveillance of Infectious Diseases (NESID) program. NESID data is collected from prefectural and municipal public health centers, and quarantine stations through an on-line reporting system.